Latest news
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial - MarketBeatMarketBeat · Tue, 11 Aug 2026 05:28:59 GMTDivesiran Eliminates Need for Phlebotomy in 88% of Patients With Polycythemia Vera - Cure TodayCure Today · Mon, 10 Aug 2026 20:53:09 GMTSilence posts mid-stage polycythemia vera win, preps for Phase III - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 18:02:18 GMTPhlebotomist Jobs Near Me Part Timecoming Soon - Toimihenkilöliitto ErtoToimihenkilöliitto Erto · Mon, 10 Aug 2026 15:50:59 GMTDivesiran Meets Primary Response End Point in Phlebotomy-Dependent Polycythemia Vera - OncLiveOncLive · Mon, 10 Aug 2026 12:41:31 GMTSilence Therapeutics: Divesiran achieved 88% response in PV, reducing phlebotomy needs with strong safety - TradingViewTradingView · Mon, 10 Aug 2026 11:55:58 GMTEdison student Catelyn Schiffman wins international HOSA phlebotomy title - Your Ohio NewsYour Ohio News · Fri, 07 Aug 2026 13:03:06 GMTManufacturers Are Building Robots to Draw Blood and Place Feeding Tubes as Hospitals Confront Staffing Gaps - Medical DailyMedical Daily · Tue, 04 Aug 2026 23:00:05 GMT